Schizophrenia was associated with 13 to 15 years of potential life lost.
The risk for offspring's development of psychosis is connected to maternal weight gain during pregnancy.
A trial at 3 mental health centers in The Netherlands revealed that patients with financial incentives have better compliance.
Participants in the risperidone group were generally more likely to achieve a significant clinical improvement in their mental state.
Cariprazine treatment led to greater improvement in the negative symptoms of schizophrenia than risperidone.
Adding high-dose B vitamins to traditional antipsychotic treatments reduces schizophrenia symptoms more than traditional treatments alone.
The FDA has approved a new treatment for adolescents between the ages of 13 and 17 years who are diagnosed with schizophrenia.
Researchers profiled which young people may do well after first-episode psychosis without medication.
These study results indicate that early intervention with low doses of metformin in patients with few metabolic abnormalities may be beneficial.
Targeting negative symptoms in patients with schizophrenia may be more effective in improving patients' QoL.
Psychiatry Advisor Articles
- Bright Light Therapy for Nonseasonal Depression: An Emerging Intervention
- Marijuana Use Associated With Worse Depression Outcomes
- Suicidal Teenagers' Hospitalization Risk Reduced by Crisis Intervention
- The End of Chemical Restraints: Expert Opinion
- Anxiety, Depression Improved by Mindfulness Meditation
- Eating Disorder Treatment Sought Infrequently by Adolescents
- Corrective Action Can Be Severe Penalty in Addition to HIPAA FInes
- Opioid-Related Death Crisis Leads to New Guidelines
- Cognition, Memory Loss Not Impacted by Evolocumab, Statin Therapy
- CBT Plays Important Role in Treatment of Benzodiazepine Dependence